REFERENCES
1. Chauhan I, Yasir M, Verma M, Singh AP.
Nanostructured Lipid Carriers: A Groundbreaking Approach for Transdermal Drug
Delivery. Adv Pharm Bull. 2020 Feb 18;10(2):150–65.
2. Li B, Ge ZQ. Nanostructured Lipid Carriers
Improve Skin Permeation and Chemical Stability of Idebenone. AAPS
PharmSciTech. 2012 Mar 11;13(1):276–83.
3. Bieber T. Atopic Dermatitis. New England
Journal of Medicine. 2008 Apr 3;358(14):1483–94.
4. Bieber T. Atopic dermatitis: an expanding
therapeutic pipeline for a complex disease. Nat Rev Drug Discov. 2022 Jan
20;21(1):21–40.
5. Elmowafy M, Al-Sanea MM. Nanostructured
lipid carriers (NLCs) as drug delivery platform: Advances in formulation and
delivery strategies. Saudi Pharmaceutical Journal. 2021 Sep;29(9):999–1012.
6. Stefanov SR, Andonova VY. Lipid
Nanoparticulate Drug Delivery Systems: Recent Advances in the Treatment of
Skin Disorders. Pharmaceuticals. 2021 Oct 26;14(11):1083.
7. Guttman-Yassky E, Krueger JG. Atopic
dermatitis and psoriasis: two different immune diseases or one spectrum? Curr
Opin Immunol. 2017 Oct;48:68–73.
8. Irvine AD, McLean WHI, Leung DYM.
Filaggrin Mutations Associated with Skin and Allergic Diseases. New England
Journal of Medicine. 2011 Oct 6;365(14):1315–27.
9. Kong HH, Oh J, Deming C, Conlan S, Grice
EA, Beatson MA, et al. Temporal shifts in the skin microbiome associated with
disease flares and treatment in children with atopic dermatitis. Genome Res.
2012 May;22(5):850–9.
10. Nakatsuji T, Chen TH, Narala S, Chun KA, Two
AM, Yun T, et al. Antimicrobials from human skin commensal bacteria protect
against Staphylococcus aureus and are deficient in atopic dermatitis.
Sci Transl Med. 2017 Feb 22;9(378).
11. Williams HC. Atopic Dermatitis. New England
Journal of Medicine. 2005 Jun 2;352(22):2314–24.
12. Laughter MR, Maymone MBC, Mashayekhi S,
Arents BWM, Karimkhani C, Langan SM, et al. The global burden of atopic
dermatitis: lessons from the Global Burden of Disease Study 1990–2017*.
British Journal of Dermatology. 2021 Feb 29;184(2):304–9.
13. Eichenfield LF, Tom WL, Berger TG, Krol A,
Paller AS, Schwarzenberger K, et al. Guidelines of care for the management of
atopic dermatitis. J Am Acad Dermatol. 2014 Jul;71(1):116–32.
14. Hussaarts KGAM, van Doorn L, Eechoute K,
Damman J, Fu Q, van Doorn N, et al. Influence of Probenecid on the
Pharmacokinetics and Pharmacodynamics of Sorafenib. Pharmaceutics. 2020 Aug
20;12(9):788.
15. Boguniewicz M, Leung DYM. Atopic dermatitis:
a disease of altered skin barrier and immune dysregulation. Immunol Rev. 2011
Jul 20;242(1):233–46.
16. Arif ST, Khan MA, Frøslev P, Zaman S uz,
Panou DA, Nielsen HM, et al. Nanostructured lipid carriers as a strategy to
enhance oral levosulpiride delivery: An in vitro and ex vivo assessment. Int J
Pharm. 2025 Jan 25;669.
17. Khan I, Sabu M, Hussein N, Omer H, Houacine
C, Khan W, et al. Trans-resveratrol-loaded nanostructured lipid carrier
formulations for pulmonary drug delivery using medical nebulizers. J Pharm
Sci. 2025 May 1;
18. Irvine AD, McLean WHI, Leung DYM. Filaggrin
Mutations Associated with Skin and Allergic Diseases. New England Journal of
Medicine. 2011 Oct 6;365(14):1315–27.
19. Skinner OP, Jurczyluk J, Baker PJ, Masters
SL, Rios Wilks AG, Clearwater MS, et al. Lack of protein prenylation promotes
NLRP3 inflammasome assembly in human monocytes. Journal of Allergy and
Clinical Immunology. 2019 Jun;143(6):2315-2317.e3.
20. Khattri S, Shemer A, Rozenblit M, Dhingra N,
Czarnowicki T, Finney R, et al. Cyclosporine in patients with atopic
dermatitis modulates activated inflammatory pathways and reverses epidermal
pathology. Journal of Allergy and Clinical Immunology. 2014 Jun;133(6):1626–34.
21. Nakatsuji T, Chen TH, Narala S, Chun KA, Two
AM, Yun T, et al. Antimicrobials from human skin commensal bacteria protect
against Staphylococcus aureus and are deficient in atopic dermatitis.
Sci Transl Med. 2017 Feb 22;9(378).
22. Contents Vol. 10, 2002–03.
Neuroimmunomodulation. 2002;10(6):383–4.
23. Niederquell A, Kuentz M. Introduction of a
Theoretical Splashing Degree to Assess the Performance of Low-Viscosity Oils
in Filling of Capsules. AAPS PharmSciTech. 2011 Mar 1;12(1):323–30.
24. Chauhan I, Yasir M, Verma M, Singh AP.
Nanostructured Lipid Carriers: A Groundbreaking Approach for Transdermal Drug
Delivery. Adv Pharm Bull. 2020 Feb 18;10(2):150–65.
25. Khan S, Sharma A, Jain V. An Overview of
Nanostructured Lipid Carriers and its Application in Drug Delivery through
Different Routes. Adv Pharm Bull. 2023 Jul 10;13(3):446–60.
26. Apostolou M, Assi S, Fatokun AA, Khan I. The
Effects of Solid and Liquid Lipids on the Physicochemical Properties of
Nanostructured Lipid Carriers. J Pharm Sci. 2021 Aug;110(8):2859–72.
27. Rasaq Kayode O, Afeez Babatunde O.
Cabenuva®: Differentiated service delivery and the community Pharmacists’
roles in achieving UNAIDS 2030 target in Nigeria. Saudi Pharmaceutical
Journal. 2021 Aug;29(8):815–9.
28. Garg J, Pathania K, Sah SP, Pawar S V.
Nanostructured lipid carriers: a promising drug carrier for targeting brain
tumours. Futur J Pharm Sci. 2022 Dec 8;8(1):25.
29. Czajkowska-Kośnik A, Szekalska M, Winnicka
K. Nanostructured lipid carriers: A potential use for skin drug delivery
systems. Vol. 71, Pharmacological Reports. Elsevier B.V.; 2019. p. 156–66.
30. Ajiboye AL, Nandi U, Galli M, Trivedi V.
Olanzapine loaded nanostructured lipid carriers via high shear homogenization
and ultrasonication. Sci Pharm. 2021 Jun 1;89(2).
31. Haider M, Abdin SM, Kamal L, Orive G.
Nanostructured Lipid Carriers for Delivery of Chemotherapeutics: A Review.
Pharmaceutics. 2020 Mar 23;12(3):288.
32. Duong VA, Nguyen TTL, Maeng HJ. Preparation
of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Drug
Delivery and the Effects of Preparation Parameters of Solvent Injection
Method. Molecules. 2020 Oct 18;25(20):4781.
33. Syed Azhar SNA, Ashari SE, Zainuddin N,
Hassan M. Nanostructured Lipid Carriers-Hydrogels System for Drug Delivery:
Nanohybrid Technology Perspective. Molecules. 2022 Jan 4;27(1):289.
34. Chauhan I, Yasir M, Verma M, Singh AP.
Nanostructured lipid carriers: A groundbreaking approach for transdermal drug
delivery. Vol. 10, Advanced Pharmaceutical Bulletin. Tabriz University of
Medical Sciences; 2020. p. 150–65.
35. Khot C, Kolekar K, Dabhole S, Mohite A,
Nadaf S, Kumbhar PS, et al. Optimized albendazole-loaded nanostructured lipid
carrier gel: a redefined approach for localized skin cancer treatment. RSC
Pharmaceutics [Internet]. 2024;1(5):1042–54. Available from: https://xlink.rsc.org/?DOI=D4PM00207E
36. Eichenfield LF, Stripling S, Fung S, Cha A,
O’Brien A, Schachner LA. Recent Developments and Advances in Atopic
Dermatitis: A Focus on Epidemiology, Pathophysiology, and Treatment in the
Pediatric Setting. Vol. 24, Pediatric Drugs. Adis; 2022. p. 293–305.
37. Balaji, Goudanavar P. Advancing topical drug
delivery: NLC innovations in dermatological therepeutics. Nano Trends. 2025
Jun;10:100108.
38. Mall J, Naseem N, Haider MdF, Rahman MA,
Khan S, Siddiqui SN. Nanostructured lipid carriers as a drug delivery system:
A comprehensive review with therapeutic applications. Intelligent Pharmacy.
2024 Sep;
39. Gomaa E, Fathi HA, Eissa NG, Elsabahy M.
Methods for preparation of nanostructured lipid carriers. Methods. 2022
Mar;199:3–8.
40. Duong VA, Nguyen TTL, Maeng HJ, Chi SC. Data
on optimization and drug release kinetics of nanostructured lipid carriers
containing ondansetron hydrochloride prepared by cold high-pressure
homogenization method. Data Brief. 2019 Oct;26:104475.
41. Gomaa E, Fathi HA, Eissa NG, Elsabahy M.
Methods for preparation of nanostructured lipid carriers. Methods. 2022 Mar
1;199:3–8.
42. Datt N, Poonuru RR, Yadav PK. Development
and characterization of griseofulvin loaded nanostructured lipid carrier gel
for treating dermatophytosis. Food Hydrocolloids for Health. 2022 Dec 1;2.
43. Trotta M, Debernardi F, Caputo O.
Preparation of solid lipid nanoparticles by a solvent emulsification–diffusion
technique. Int J Pharm. 2003 May;257(1–2):153–60.
44. Palaria B, Tiwari V, Tiwari A, Aslam R,
Kumar A, Sahoo BM, et al. Nanostructured Lipid Carriers: A Promising Carrier
in Targeted Drug Delivery System. Current Nanomaterials. 2023 Apr;8(1):23–43.
45. Wairkar S, Patel D, Singh A. Nanostructured
lipid carrier based dermal gel of cyclosporine for atopic dermatitis-in vitro
and in vivo evaluation. J Drug Deliv Sci Technol. 2022 Jun 1;72.
46. Osanlou R, Emtyazjoo M, Banaei A,
Hesarinejad MA, Ashrafi F. Preparation of solid lipid nanoparticles and
nanostructured lipid carriers containing zeaxanthin and evaluation of
physicochemical properties. Colloids Surf A Physicochem Eng Asp. 2022 May 20;641.
47. Teaima MH, Badawi NM, Attia DA, El-Nabarawi
MA, Elmazar MM, Mousa SA. Efficacy of pomegranate extract loaded solid lipid
nanoparticles transdermal emulgel against Ehrlich ascites carcinoma.
Nanomedicine. 2022 Jan 1;39.
48. Ayesha BT, Erum A, Shahid N, Tulain UR,
Saleem U. An effective approach in osteoarthritis: Diacerein-loaded solid
lipid nanoparticles, preparation and evaluation for targeted therapy. J Drug
Deliv Sci Technol. 2025 Jun 1;108.
49. Vogelaar A, Marcotte S, Cheng J, Oluoch B,
Zaro J. Use of Microfluidics to Prepare Lipid-Based Nanocarriers.
Pharmaceutics. 2023 Mar 24;15(4):1053.
50. Ahalwat S, Bhatt DC, Rohilla S. Quality by
Design (QbD) based Formulation Optimization of Isoniazid Loaded Novel
Nanostructured Lipid Carriers for Controlled Release Effect. J Pharm Innov.
2023 Dec 21;18(4):1685–700.
51. Sharma G, Thakur K, Raza K, Singh B, Katare
OP. Nanostructured Lipid Carriers: A New Paradigm in Topical Delivery for
Dermal and Transdermal Applications. Crit Rev Ther Drug Carrier Syst.
2017;34(4):355–86.
52. Rizwanullah Md, Ahmad MZ, Garg A, Ahmad J.
Advancement in design of nanostructured lipid carriers for cancer targeting
and theranostic application. Biochimica et Biophysica Acta (BBA) - General
Subjects. 2021 Sep;1865(9):129936.
53. Bhavar A, Kolekar KA, Yadav T, Kole K,
Bhagwat D, Singh SK, et al. Formulation of repurposed celecoxib-loaded
nanostructured lipid carriers using Box-Behnken design, its characterization,
and anticancer evaluation. Ann Pharm Fr. 2025;
54. Sharma S, Thukral R, Singla L Das, Singla N,
Choudhury D. Quercetin-loaded solid lipid nanoparticles for enhanced
anti-helminthic activity. Int J Pharm. 2025 Mar 15;672.
55. Pooja D, Tunki L, Kulhari H, Reddy BB,
Sistla R. Optimization of solid lipid nanoparticles prepared by a single
emulsification-solvent evaporation method. Data Brief. 2016 Mar;6:15–9.
56. Hemrajani C, Negi P, Parashar A, Gupta G,
Jha NK, Singh SK, et al. Overcoming drug delivery barriers and challenges in
topical therapy of atopic dermatitis: A nanotechnological perspective. Vol.
147, Biomedicine and Pharmacotherapy. Elsevier Masson s.r.l.; 2022.
57. Pooja D, Tunki L, Kulhari H, Reddy BB,
Sistla R. Optimization of solid lipid nanoparticles prepared by a single
emulsification-solvent evaporation method. Data Brief. 2016 Mar;6:15–9.
58. Ahalwat S, Bhatt DC, Rohilla S. Quality by
Design (QbD) based Formulation Optimization of Isoniazid Loaded Novel
Nanostructured Lipid Carriers for Controlled Release Effect. J Pharm Innov.
2023 Dec 21;18(4):1685–700.
59. Dash SK, Patra CN, Acharjya SK, Jena GK,
Panigrahi KC, Kumar NK, et al. Development and Characterization of
Paliperidone Loaded Nanostructured Lipid Carrier. Indian Journal of
Pharmaceutical Education and Research. 2022 Oct 1;56(4):1003–12.
60. Vogelaar A, Marcotte S, Cheng J, Oluoch B,
Zaro J. Use of Microfluidics to Prepare Lipid-Based Nanocarriers.
Pharmaceutics. 2023 Mar 24;15(4):1053.
61. Umerska A, Mouzouvi CRA, Bigot A, Saulnier
P. Formulation and nebulization of fluticasone propionate-loaded lipid
nanocarriers. Int J Pharm. 2015 Aug 11;493(1–2):224–32.
62. Chavan SS, Ingle SG, Vavia PR. Preparation
and characterization of solid lipid nanoparticle-based nasal spray of
budesonide. Drug Deliv Transl Res. 2013 Oct;3(5):402–8.
63. Üner M. Characterization and Imaging of
Solid Lipid Nanoparticles and Nanostructured Lipid Carriers. In: Handbook of
Nanoparticles. Cham: Springer International Publishing; 2016. p. 117–41.
64. Waghule T, Rapalli VK, Gorantla S, Saha RN,
Dubey SK, Puri A, et al. Nanostructured Lipid Carriers as Potential Drug
Delivery Systems for Skin Disorders. Curr Pharm Des. 2020 Oct
23;26(36):4569–79.